Genoskin

Genoskin

Private
ToulouseHealthcare & Life Scienceshttps://www.genoskin.com

Last Round

Debt

Sep 16, 2025

Total Funding Raised

$12.96M

Momentum Score

25 /100

Company Overview

Genoskin is a biotechnology company that provides ready-to-use, live human skin models for pharmaceutical, cosmetic, and chemical product testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

ex vivo human skin modelscontract research organizationCROalternative to animal testingpreclinical testinghuman skin explantstoxicity testingefficacy testinghuman-relevant modelsimmunocompetent skin modelscosmetic testinginjection site reactionsdrug developmentpsoriasis modelvaccine developmenttissue imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genoskin Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genoskin Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtSep 16, 2025
Series ASep 16, 2025
GrantAug 29, 2019
GrantMar 7, 2018
Early FundingAug 29, 2017
Grant
Jun 14, 2011

Key People

Founding team and executive leadership

Pascal Descargues

Founder And CEO, CEO

Founding Team

Frederick Roques

Chief Financial Officer

Executive Team

Claire Jardet

Chief Operating Officer

Executive Team

Genoskin Investors

Notable investors and investment history

InvestorRounds
GSO InnovationSeries A
BpifranceGrant, Debt
CA Toulouse 31 InitiativesSeries A
Caisse d'Epargne Midi-PyrénéesSeries A
OCCTESeries A
BpifranceSeries A
BNP ParibasSeries A, Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Fabrice Bouteille appointed to strengthen governance.

  • Sep 16, 2025

    $9M round completed.

Genoskin Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genoskin Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genoskin's valuation, stock price, and market status.

Firmographic Details

HeadquartersToulouse
Employee Range56
Year Founded2011
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.